Skip to main content
FinSpry Logo
FinSpry
MXCT logo
MXCT
(NASDAQ)
MaxCyte, Inc.
$0.75-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

MaxCyte (MXCT) Stock Price & Financial Analysis

MaxCyte Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.71 - $0.75
52-Week High$2.96
52-Week Low$0.64
Open$0.71
Volume1.50M
Average Volume (3M)1.50M
Market Cap79.92M
Shares Outstanding106.61M
Price to Sales (P/S)2.30
Price to Book (P/B)0.44
EV/EBITDA-1.84
Revenue (TTM)34.42M
Net Income (TTM)-45.63M
Free Cash Flow (TTM)-41.23M
EPS (TTM)$-0.43
Profit Margin-132.58%
Operating Margin-146.76%
Return on Equity (ROE)-25.31%
Debt to Equity0.09
50-Day MA$0.82
200-Day MA$1.46
52-Week Change-72.54%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About MaxCyte

What is the current stock price for MXCT?

As of the latest trading session, MXCT stock trades at $0.75. The 52-week range is $0.64–$2.96, with a day range of $0.71–$0.75.

What is the P/E ratio for MXCT?

The P/E ratio (Price-to-Earnings) for MXCT is shown in the Key Statistics section. This valuation metric helps compare MaxCyte, Inc. to industry peers.

Does MXCT pay dividends?

MaxCyte does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MXCT?

Based on 1 analyst, the consensus for MXCT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of MXCT?

MaxCyte's market capitalization is $79.9M, classifying it as a micro-cap company. MaxCyte operates in the Healthcare sector within the Medical Devices industry.